Core Viewpoint - The National Market Supervision Administration of China has penalized Nala Zun Tuo (Guangzhou) Dairy Co., Ltd. for publishing false advertising related to health claims and misleading content in their product promotions [1] Group 1: Company Actions - Nala Zun Tuo (Guangzhou) Dairy Co., Ltd. was fined 450,000 yuan for including false claims in their advertisements, such as references to disease prevention and treatment [1] - The company’s advertisement for "camel milk powder" included misleading statements about being part of the "Belt and Road Initiative" and offered "discount sales quotas" in relevant provinces [1] Group 2: Regulatory Response - The fine was imposed by the Haizhu District Market Supervision Bureau in Guangzhou, based on violations of the Advertising Law of the People's Republic of China [1] - The regulatory body found that the company failed to use citation content accurately and truthfully in their advertisements [1]

Core Viewpoint - The article highlights the efforts of the Yunfu market supervision department in addressing advertising violations to create a fair and safe consumption environment for the public [1] Group 1: Regulatory Actions - The Yunfu market supervision department has conducted multiple special governance actions targeting key areas and issues related to advertising violations [1] - A series of administrative penalties have been imposed on companies for publishing false advertisements, including orders to cease publication and fines [2][3][4][5][6][8] Group 2: Case Summaries - Case 1: A company was penalized for advertising a food product with claimed therapeutic effects, violating the Advertising Law [2] - Case 2: A food company was fined for misleading claims about a product being "oil-free," lacking evidence to support the assertion [3] - Case 3: A health food business was found to have made false claims regarding the therapeutic benefits of its product, leading to regulatory action [4] - Case 4: A pharmaceutical company faced penalties for advertising prescription drugs inappropriately, violating advertising regulations [5] - Case 5: A dental service provider was penalized for failing to provide necessary approval for its medical advertising [6] - Case 6: A stone company was fined for misleading product specifications that lacked valid verification, impacting consumer decisions [8]

Core Points - Huatu Education Technology Co., Ltd. Jinhua Branch was fined RMB 20,000 for publishing illegal training advertisements [1][2][3] Group 1: Company Information - Huatu Education is a wholly-owned subsidiary of Huatu Shanding (300492.SZ) [2] - The company operates over 1,000 learning centers nationwide and employs more than 10,000 staff [2] Group 2: Regulatory Action - The Jinhua Market Supervision Administration ordered the company to correct its illegal behavior and imposed a fine [1][2] - The illegal advertisement was published on the company's WeChat official account on January 27, 2024, violating Article 4, Paragraph 1 of the Advertising Law of the People's Republic of China [2] - The administrative penalty decision was made on September 24, 2025, and the company must comply within 15 days of receiving the decision [2]

Group 1 - Shenzhen Aier Eye Hospital was fined 717.5 yuan for illegal medical advertising by the Shenzhen Market Supervision Administration [1][2] - The penalty was based on the Advertising Law of the People's Republic of China, which stipulates fines for various advertising violations [2] - The penalty decision was made on April 18, 2025, and the hospital is a subsidiary of Aier Eye Hospital Group, holding a 91% stake [3] Group 2 - In 2023, Shenzhen Aier Eye Hospital reported an operating income of 296 million yuan and a net profit of 58.5 million yuan [3] - The hospital primarily engages in ophthalmology medical services and optical dispensing [3] - The registered capital of Shenzhen Aier Eye Hospital is 45 million yuan [4]